Psoriasis drug showdown: methotrexate vs tofacitinib
NCT ID NCT07261306
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This study compares two oral medications, methotrexate and tofacitinib, to see which works better for chronic plaque psoriasis. It involves 75 adults aged 18-70 with moderate to severe psoriasis that hasn't responded well to topical treatments. The main goal is to measure how many patients achieve at least a 75% reduction in psoriasis severity after 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lahore general hospital
RECRUITINGLahore, Punjab Province, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.